SCHEMBL30962809

SCHEMBL30962809

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C#N)c2)nc(-c2c(Cl)ccc(O)c2C)c1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 1/20 0.37
▸ TBK1 Q9UHD2 6/20 0.36
▸ JAK2 O60674 2/20 0.36
▸ ALK Q9UM73 1/20 0.36
▸ PTK2 Q05397 3/20 0.35
▸ PAK1 Q13153 4/20 0.35
▸ PKMYT1 Q99640 2/20 0.35
▸ WEE1 P30291 2/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962572 0.91 WEE1 (0.41) EHMT2TBK1JAK2ALKPAK1
SCHEMBL30962858 0.88 EHMT2 (0.37) EHMT2TBK1JAK2ALKPTK2
SCHEMBL30962632 0.87 WEE1 (0.43) EHMT2TBK1JAK2ALKPTK2
SCHEMBL30962668 0.85 WEE1 (0.41) EHMT2TBK1JAK2ALKPAK1
SCHEMBL30962775 0.85 ALK (0.42) EHMT2TBK1JAK2ALKPKMYT1
SCHEMBL30962797 0.83 WEE1 (0.47) EHMT2TBK1JAK2ALKPTK2
SCHEMBL30962848 0.83 HSP90AA1 (0.37) EHMT2JAK2ALK
SCHEMBL30962777 0.82 WEE1 (0.46) EHMT2TBK1JAK2ALKPTK2
SCHEMBL30962700 0.81 WEE1 (0.43) EHMT2TBK1JAK2ALKPAK1
SCHEMBL30962912 0.81 TBK1 (0.41) EHMT2TBK1JAK2ALKPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback